Effects of damage‑regulated autophagy regulator gene on the SGC7901 human gastric cancer cell line

Zhu,Bao‑Song; Zhao,Kui; Jia,Xin; Wu,Yong‑You; Xing,Chun‑Gen

doi:10.3892/ol.2014.2220

Effects of damage‑regulated autophagy regulator gene on the SGC7901 human gastric cancer cell line

Authors:
- Bao‑Song Zhu
- Kui Zhao
- Xin Jia
- Yong‑You Wu
- Chun‑Gen Xing
View Affiliations

Affiliations: Department of General Surgery, The Second Affiliated Hospital, Soochow University, Suzhou, Jiangsu 215021, P.R. China
Published online on: June 4, 2014 https://doi.org/10.3892/ol.2014.2220
Pages: 657-662

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effects of the adenoviral‑mediated autophagy gene, damage‑regulated autophagy regulator (DRAM), on the proliferation and autophagy of SGC7901 human gastric cancer cells in vitro. The recombinant adenovirus, AdMax‑pDC315‑DRAM‑EGFP, working as a virus vector of DRAM was constructed and infected into the SGC7901 human gastric cancer cell line. The MTT assay was used to determine the growth rate of the SGC7901 cells. Activation of autophagy was monitored with monodansylcadaverin (MDC) staining following AdMax‑pDC315‑DRAM‑EGFP treatment. Immunofluorescent staining was used to examine the expression of microtubule‑associated protein 1 light chain 3 (LC3), and western blotting was used to examine the expression of apoptosis‑ and autophagy‑associated proteins, including Beclin1, p53, p21 and B‑cell lymphoma 2 (Bcl‑2), in the culture supernatant. The viability of the SGC7901 cells was activated by AdMax‑pDC315‑DRAM‑EGFP treatment. The AdMax‑pDC315‑DRAM‑EGFP‑treated cells exhibited positive LC3 expression detected by immunoreactivity and MDC staining. Inductions in the expression of the apoptosis‑related proteins, p53 and p21, and the autophagic protein, Beclin1, were revealed by western blot analysis. By contrast, downregulation of the apoptosis‑related protein, Bcl‑2, following AdMax‑pDC315‑DRAM‑EGFP treatment was identified. In conclusion, the present study demonstrated that AdMax‑pDC315‑DRAM‑EGFP treatment resulted in upregulation of the level of autophagy and induction of cell proliferation in the SGC7901 human gastric cancer cell line in vitro.

View Figures

View References

1	Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol. 12:354–362. 2006.
2	Crighton D and Ryan KM: Splicing DNA-damage responses to tumor cell death. Biochim Biophys Acta. 1705:3–15. 2004.
3	Ryan KM, Phillips AC and Vousden KH: Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol. 13:332–337. 2001.
4	Feng Z, Zhang H, Levine AJ and Jin S: The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA. 102:8204–8209. 2005.
5	Crighton D, Wilkinson S, O’Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T and Ryan KM: DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 126:121–134. 2006.
6	Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science. 290:1717–1721. 2000.
7	Kerley-Hamilton JS, Pike AM, Hutchinson JA, Freemantle SJ and Spinella MJ: The direct p53 target gene, FLJ11259/DRAM, is a member of a novel family of transmembrane proteins. Biochim Biophys Acta. 1769:209–219. 2007.
8	Crighton D, O’Prey J, Bell HS and Ryan KM: p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ. 14:1071–1079. 2007.
9	Alesci S, Ramsey WJ, Bornstein SR, Chrousos GP, Hornsby PJ, Benvenga S, Trimarchi F and Ehrhart-Bornstein M: Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy. Proc Natl Acad Sci USA. 99:7484–7489. 2002.
10	Niemann A, Takatsuki A and Elsässer HP: The lysosomotropic agent monodansylcadaverine also acts as a solvent polarity probe. J Histochem Cytochem. 48:251–258. 2000.
11	Ikeda K, Monden T, Kanoh T, Tsujie M, Izawa H, Haba A, Ohnishi T, Sekimoto M, Tomita N, Shiozaki H and Monden M: Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem. 46:397–403
12	Biederbick A, Kern HF and Elsässer HP: Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 66:3–14. 1995.
13	Yoshimori T: Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun. 313:453–458. 2004.
14	Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R and Kroemer G: Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 16:87–93. 2009.
15	Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta. 1793:1524–1532. 2009.
16	White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 15:5308–5316. 2009.
17	Soussi T: p53 alterations in human cancer: more questions than answers. Oncogene. 26:2145–2156. 2007.
18	Soussi T and Lozano G: p53 mutation heterogeneity in cancer. Biochem Biophys Res Commun. 331:834–842. 2005.
19	Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
20	Yue Z, Jin S, Yang C, Levine AJ and Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 100:15077–15082. 2003.
21	Zeng X, Overmeyer JH and Maltese WA: Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci. 119:259–270. 2006.
22	Lum JJ, DeBerardinis RJ and Thompson CB: Autophagy in metazoans: cell survival in the land of plenty (review). Nat Rev Mol Cell Biol. 6:439–448. 2005.
23	Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC and Levine B: Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 59:59–65. 1999.
24	Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G and Levine B: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 112:1809–1820. 2003.
25	Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 122:927–939. 2005.
26	Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R, Mathiasen IS and Jäättelä M: Control of macroautophagy by calcium, calmodulindependent kinase kinase-beta, and Bcl-2. Mol Cell. 25:193–205. 2007.
27	Oberstein A, Jeffrey PD and Shi Y: Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem. 282:13123–13132. 2007.
28	Le NT and Richardson DR: Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Carcinogenesis. 24:1045–1058. 2003.